What changed from existing technology?
This study shows that high sugar levels make some cancer cells resistant to the drug metformin by changing how they use energy, which helps them survive treatment.
This is the first study to link glucose metabolism to metformin resistance in colorectal cancer stem cells through histone lactylation, a new mechanism not previously described.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 0
- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This finding suggests that targeting histone lactylation or lipid metabolism could enhance the effectiveness of metformin in treating colorectal cancer, particularly in patients with high glucose levels.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.